In particular, FTO suppressed the expression of tumor suppressors, including ankyrin repeat and SOCS box containing 2 (ASB2) and retinoic acid receptor alpha (RARA) by eliminating m6A sites. The gene discussed is FTO; the disease is neoplasm.